Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Update on gastric cancer treatments and gene therapies.
Biagioni A, Skalamera I, Peri S, Schiavone N, Cianchi F, Giommoni E, Magnelli L, Papucci L. Biagioni A, et al. Among authors: giommoni e. Cancer Metastasis Rev. 2019 Sep;38(3):537-548. doi: 10.1007/s10555-019-09803-7. Cancer Metastasis Rev. 2019. PMID: 31486976 Review.
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey.
Reni M, Giommoni E, Bergamo F, Cavanna L, Simionato F, Spada M, Di Marco M, Bernardini I, Cordio SS, Latiano T, Spallanzani A, Silvestris N, Cardellino GG, Bonomi M, Milella M, Luchena G, Tamburini E, Macchini M, Orsi G, Modesti M, Procaccio L, Santoni A, De Simone I, Caldirola L, Galli F, Pinto C. Reni M, et al. Among authors: giommoni e. Pancreatology. 2024 Nov;24(7):1160-1166. doi: 10.1016/j.pan.2024.10.002. Epub 2024 Oct 3. Pancreatology. 2024. PMID: 39389862 Free article.
HER2 loss in HER2-positive gastric or gastroesophageal cancer after trastuzumab therapy: Implication for further clinical research.
Pietrantonio F, Caporale M, Morano F, Scartozzi M, Gloghini A, De Vita F, Giommoni E, Fornaro L, Aprile G, Melisi D, Berenato R, Mennitto A, Volpi CC, Laterza MM, Pusceddu V, Antonuzzo L, Vasile E, Ongaro E, Simionato F, de Braud F, Torri V, Di Bartolomeo M. Pietrantonio F, et al. Among authors: giommoni e. Int J Cancer. 2016 Dec 15;139(12):2859-2864. doi: 10.1002/ijc.30408. Epub 2016 Sep 16. Int J Cancer. 2016. PMID: 27578417
Perioperative Tailored Treatments for Gastric Cancer: Times Are Changing.
Lavacchi D, Fancelli S, Buttitta E, Vannini G, Guidolin A, Winchler C, Caliman E, Vannini A, Giommoni E, Brugia M, Cianchi F, Pillozzi S, Roviello G, Antonuzzo L. Lavacchi D, et al. Among authors: giommoni e. Int J Mol Sci. 2023 Mar 2;24(5):4877. doi: 10.3390/ijms24054877. Int J Mol Sci. 2023. PMID: 36902306 Free PMC article. Review.
VEGF-A clinical significance in gastric cancers: immunohistochemical analysis of a wide Italian cohort.
Lastraioli E, Boni L, Romoli MR, Crescioli S, Taddei A, Beghelli S, Tomezzoli A, Vindigni C, Saragoni L, Messerini L, Bernini M, Bencini L, Giommoni E, Freschi G, Di Costanzo F, Scarpa A, Morgagni P, Farsi M, Roviello F, De Manzoni G, Bechi P, Arcangeli A; Gruppo Italiano di Ricerca Cancro Gastrico (GIRCG). Lastraioli E, et al. Among authors: giommoni e. Eur J Surg Oncol. 2014 Oct;40(10):1291-8. doi: 10.1016/j.ejso.2014.03.028. Epub 2014 Apr 12. Eur J Surg Oncol. 2014. PMID: 24784776
Biomarkers of Primary Resistance to Trastuzumab in HER2-Positive Metastatic Gastric Cancer Patients: the AMNESIA Case-Control Study.
Pietrantonio F, Fucà G, Morano F, Gloghini A, Corso S, Aprile G, Perrone F, De Vita F, Tamborini E, Tomasello G, Gualeni AV, Ongaro E, Busico A, Giommoni E, Volpi CC, Laterza MM, Corallo S, Prisciandaro M, Antista M, Pellegrinelli A, Castagnoli L, Pupa SM, Pruneri G, de Braud F, Giordano S, Cremolini C, Di Bartolomeo M. Pietrantonio F, et al. Among authors: giommoni e. Clin Cancer Res. 2018 Mar 1;24(5):1082-1089. doi: 10.1158/1078-0432.CCR-17-2781. Epub 2017 Dec 5. Clin Cancer Res. 2018. PMID: 29208673 Free article.
Ramucirumab as Second-Line Therapy in Metastatic Gastric Cancer: Real-World Data from the RAMoss Study.
Di Bartolomeo M, Niger M, Tirino G, Petrillo A, Berenato R, Laterza MM, Pietrantonio F, Morano F, Antista M, Lonardi S, Fornaro L, Tamberi S, Giommoni E, Zaniboni A, Rimassa L, Tomasello G, Sava T, Spada M, Latiano T, Bittoni A, Bertolini A, Proserpio I, Bencardino KB, Graziano F, Beretta G, Galdy S, Ventriglia J, Scagnoli S, Spallanzani A, Longarini R, De Vita F. Di Bartolomeo M, et al. Among authors: giommoni e. Target Oncol. 2018 Apr;13(2):227-234. doi: 10.1007/s11523-018-0562-5. Target Oncol. 2018. PMID: 29582224
48 results